Amgen (AMGN): return calculator
Amgen (AMGN) shares, one of the world's largest biotechnology companies, listed in New York.
Updated
- Type
- Stocks
- Market
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Data range
- 2016-07 – 2026-06 · 10 years
- Source
- Yahoo Finance
US$1,000 invested 9 years ago would be worth today
US$2,644
+164.4% total return
Try your own values in the calculators below.
Return calculator
Pick an amount and a period to see what an investment in Amgen (AMGN) would be worth today. By default we include reinvested dividends (total return).
Lump sum
What a one-off investment would be worth today.
Monthly investing (DCA)
What investing the same amount every month would be worth.
Estimate before taxes, fees and currency-conversion costs. Past performance does not guarantee future returns.
Investment growth
Performance
Data for the last 10 years · 2016-07 → 2026-06
Comparison with the market
US$1,000 invested vs S&P 500 ETF (SPY):
- Amgen (AMGN)
- US$2,718
- S&P 500 ETF (SPY)
- US$3,793
Amgen (AMGN) trailed S&P 500 ETF (SPY) over this period.
Risk & drawdowns
The largest peak-to-trough drop in the window was -21.7%. An investor who bought near the prior peak would have seen the investment fall significantly before recovering.
Scenarios
Illustrative results based on the available data.
US$1,000 5 years ago
US$1,666
lump sum, +66.6393570854148% return
US$100/mo for 5 years
US$8,576
invested US$6,100
If it repeats +10.61%/yr for 10 years
US$2,741
projection from US$1,000 (hypothetical)
About Amgen (AMGN)
Amgen is one of the world's largest biotechnology companies. Unlike traditional pharmaceutical firms, it specialised in "biologic" drugs, made from living cells. Its products include Enbrel (arthritis), Prolia and Repatha (cholesterol), and it has obesity candidates in development. It scaled up with the 2023 acquisition of Horizon Therapeutics.
It trades on the NASDAQ under the ticker AMGN and is part of the S&P 500 and the Dow Jones. It is a dividend stock. As across the industry, growth depends on sustaining sales of current drugs and on approving and launching new ones, in a sector where clinical trials are expensive and uncertain.
Related calculators
Other assets
Frequently asked questions
How much did Amgen (AMGN) return over the last 10 years?
Do these calculations include dividends?
Do they include taxes or fees?
What currency are the values in?
Does past performance predict the future?
Sources & methodology
Prices: Yahoo Finance. Monthly series, total return (dividends reinvested). Data through 2026-06-23.
Total return assumes dividends are reinvested; you can turn that off to see price-only appreciation. Values are estimates before taxes, fees and currency-conversion costs.
Page generated and reviewed by the Calculadora Capital editorial team. Last updated 2026-06-23.